We are excited to announce that our MosaiQ AiPlex® Celiac Disease (CD) solution has obtained Medical Device Authority (MDA) registration in Malaysia! The registration confirms the safety, quality, and effectiveness of our system.
With this approval, AliveDx is now authorized to market and sell the MosaiQ AiPlex CD solution in Malaysia.
“We are delighted to have obtained MDA registration in Malaysia! This milestone strengthens our commitment to providing high-quality diagnostic solutions across the Asian region, empowering clinicians with reliable tools for improved patient care,” said Khaled Hamed, Head of Global Emerging Markets.
For further information, please visit the MosaiQ AiPlex CD pages, and the MDA website.
